This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1977
Title: Seijun Wada: Innovator in Serological Reagents
Introduction
Seijun Wada is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of serological reagents, particularly through his innovative patent. His work has implications for various serologic reactions, enhancing the quality and reliability of testing methods.
Latest Patents
Wada holds a patent for a serological reagent and its preparation. The patent describes a method for preparing a latex reagent by allowing latex particles to adsorb a nonionic surfactant of ethylene oxide type. This process sensitizes the latex particles with a serologically active substance, such as an antigen or antibody, and suspends them in an aqueous solvent. The resulting latex reagent exhibits excellent quality, characterized by high stability and sensitivity in serologic reactions. This innovation can be employed advantageously in a broad variety of serologic applications.
Career Highlights
Seijun Wada is associated with Takeda Chemical Industries, Inc., a leading company in the pharmaceutical and biotechnology sectors. His work at Takeda has allowed him to focus on developing advanced serological reagents that improve diagnostic capabilities.
Collaborations
Wada has collaborated with notable colleagues, including Yukio Sato and Shigetaka Matsuzawa. These collaborations have contributed to the advancement of research and development in the field of serological testing.
Conclusion
Seijun Wada's contributions to the field of serological reagents highlight his innovative spirit and dedication to improving diagnostic methods. His patent reflects a significant advancement in the quality and sensitivity of serologic reactions, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
